Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-28
Pay. Date : 2013-08-13
DMF Number : 13195
Submission : 1998-09-23
Status :
Type : II
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14319
Submission : 1999-07-01
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
About the Company : Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipmen...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Parenteral
Fillers, Diluents & Binders
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
26 Jul 2024
Reply
12 Jul 2022
Reply
30 Apr 2022
Reply
15 Nov 2019
Reply
31 Oct 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
30
PharmaCompass offers a list of Milrinone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Milrinone manufacturer or Milrinone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Milrinone manufacturer or Milrinone supplier.
PharmaCompass also assists you with knowing the Milrinone API Price utilized in the formulation of products. Milrinone API Price is not always fixed or binding as the Milrinone Price is obtained through a variety of data sources. The Milrinone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Milrinone Lactate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milrinone Lactate, including repackagers and relabelers. The FDA regulates Milrinone Lactate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milrinone Lactate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milrinone Lactate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Milrinone Lactate supplier is an individual or a company that provides Milrinone Lactate active pharmaceutical ingredient (API) or Milrinone Lactate finished formulations upon request. The Milrinone Lactate suppliers may include Milrinone Lactate API manufacturers, exporters, distributors and traders.
click here to find a list of Milrinone Lactate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Milrinone Lactate DMF (Drug Master File) is a document detailing the whole manufacturing process of Milrinone Lactate active pharmaceutical ingredient (API) in detail. Different forms of Milrinone Lactate DMFs exist exist since differing nations have different regulations, such as Milrinone Lactate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Milrinone Lactate DMF submitted to regulatory agencies in the US is known as a USDMF. Milrinone Lactate USDMF includes data on Milrinone Lactate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Milrinone Lactate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Milrinone Lactate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Milrinone Lactate Drug Master File in Japan (Milrinone Lactate JDMF) empowers Milrinone Lactate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Milrinone Lactate JDMF during the approval evaluation for pharmaceutical products. At the time of Milrinone Lactate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Milrinone Lactate suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Milrinone Lactate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Milrinone Lactate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Milrinone Lactate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Milrinone Lactate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Milrinone Lactate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Milrinone Lactate suppliers with NDC on PharmaCompass.
Milrinone Lactate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milrinone Lactate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milrinone Lactate GMP manufacturer or Milrinone Lactate GMP API supplier for your needs.
A Milrinone Lactate CoA (Certificate of Analysis) is a formal document that attests to Milrinone Lactate's compliance with Milrinone Lactate specifications and serves as a tool for batch-level quality control.
Milrinone Lactate CoA mostly includes findings from lab analyses of a specific batch. For each Milrinone Lactate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milrinone Lactate may be tested according to a variety of international standards, such as European Pharmacopoeia (Milrinone Lactate EP), Milrinone Lactate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milrinone Lactate USP).
Comment (2)
